Link (Oxford Academic) Rushworth GF, Megson IL
But medications leading to so much weight loss may be needed for people with severe obesity (a BMI of 35 or more) or the 10% of patients who dont respond to GLP-1 medications and need something more powerful, Azar said
Moreover, the rising demand for GLP-1 drugs for diabetes and weight loss has increased outsourcing and compounding, which, in turn, heightens regulatory scrutiny of sterility procedures
Intestinal Research
Factors influencing long-term continuation include the degree of weight loss achieved, improvement in obesity-related comorbidities, side effect profile, cost considerations, and patient preference
Germany leads regional development as functional beverages gain traction with health-conscious consumers, and yerba mate is increasingly viewed as a more balanced caffeine source